🇺🇸 LGND — Ligand Pharmaceuticals Incorporated

Salud Compra fuerte
← Volver

Precio actual

306,20 USD

Máx. histórico

322,75

7 días

Split 1603:1000 del 02/11/2022

Caída desde máximo

-5,13%

Rango 52 semanas

175,89 – 326,63

Variación hoy

+2,41%

Cierre anterior

299,00

Rango de hoy

297,84 – 308,26

Volumen hoy

130.173

Peor caída histórica

-93,34%

06/03/2000 → 19/11/2008

Recuperado en 2694 días

Volatilidad anualizada ⓘ

59,76%

Información
Nombre completo
Ligand Pharmaceuticals Incorporated
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
47
PER ⓘ
122,97 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
351,33 USD (puede no estar actualizado)
Primera cotización
18/11/1992
Precio actualizado
hace 21 horas
Sobre la empresa

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.

Dividendos repartidos Total últimos 12 meses: 0,0000 USD · Yield: 0,00%
Fecha de pago Importe por participación
03/04/2007 9,3575 USD
Splits Registrados en el histórico de precios
Fecha Ratio
02/11/2022 1603:1000
19/11/2010 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
13/01/2010 7,45 7,75 7,37 7,71 +3,52% 5,03% 74.299
12/01/2010 7,67 7,75 7,41 7,45 -3,87% 4,39% 94.764
11/01/2010 7,71 7,86 7,56 7,75 +1,47% 3,88% 71.627
08/01/2010 7,82 7,86 7,49 7,64 -2,86% 4,78% 87.818
07/01/2010 7,67 7,86 7,52 7,86 +2,44% 4,39% 121.454
06/01/2010 7,79 7,94 7,37 7,67 -1,91% 7,21% 395.674
05/01/2010 8,12 8,16 7,75 7,82 -3,69% 5,07% 183.517
04/01/2010 8,23 8,61 7,97 8,12 +0,00% 7,73% 369.037
31/12/2009 7,90 8,23 7,67 8,12 +2,36% 7,11% 126.183
30/12/2009 8,01 8,05 7,64 7,94 -1,85% 5,14% 169.384
29/12/2009 8,12 8,23 7,94 8,08 -1,37% 3,69% 47.289
28/12/2009 8,27 8,35 7,97 8,20 +0,00% 4,52% 101.363
24/12/2009 7,97 8,35 7,67 8,20 +2,82% 8,45% 101.229
23/12/2009 8,46 8,50 7,90 7,97 -5,33% 7,08% 82.020
22/12/2009 7,41 8,68 7,30 8,42 +13,64% 18,69% 261.823
21/12/2009 7,15 7,56 7,11 7,41 +3,13% 6,28% 106.199
18/12/2009 7,11 7,67 6,92 7,19 +4,92% 10,53% 368.476
17/12/2009 7,00 7,04 6,77 6,85 -3,17% 3,74% 110.019
16/12/2009 7,11 7,22 6,96 7,07 +0,53% 3,69% 63.425
15/12/2009 7,19 7,19 7,00 7,04 -2,59% 2,60% 110.473
14/12/2009 7,07 7,26 6,89 7,22 +2,12% 5,29% 105.531
11/12/2009 7,11 7,19 6,96 7,07 +0,00% 3,16% 58.483
10/12/2009 7,11 7,37 6,92 7,07 -0,53% 6,32% 82.314
09/12/2009 7,00 7,15 6,96 7,11 +2,15% 2,67% 69.223
08/12/2009 7,19 7,37 6,96 6,96 -3,63% 5,73% 99.626
07/12/2009 7,26 7,45 7,15 7,22 -1,02% 4,12% 70.879
04/12/2009 7,19 7,56 7,07 7,30 +3,72% 6,77% 105.371
03/12/2009 7,22 7,56 7,00 7,04 -2,08% 7,77% 185.975
02/12/2009 7,07 7,19 6,89 7,19 +1,59% 4,23% 407.536
01/12/2009 7,52 7,60 7,04 7,07 -4,55% 7,46% 845.770